Drawing for AXLIPHY

USPTO serial 97715622

AXLIPHY

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
FICKES, JERI J
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AXLIPHY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Paul C. Llewellyn

PAUL C. LLEWELLYN ARNOLD & PORTER KAYE SCHOLER LLP601 MASSACHUSETTS AVE., NWIP DOCKETINGIP DOCKETING, DC 20001

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals in the nature of immuno-oncology preparations; Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Anti-cancer preparationsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 16, 2024MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Jan 13, 2024ABN5ABANDONMENT - AFTER PUBLICATION—
Jan 12, 2024EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Nov 16, 2023ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 31, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 31, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 11, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 20, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 20, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Sep 20, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 20, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 20, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 17, 2023DOCKASSIGNED TO EXAMINER—
Dec 16, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 16, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance